FDA Inspection
Bora Pharmaceuticals Injectables IncBora Pharmaceuticals Injectables Inc – FDA Inspection, Jun 13, 2018
Record Details
This FDA Inspection record concerns Bora Pharmaceuticals Injectables Inc, with an inspection on June 13, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ed35f170-6055-4363-916e-59e1f8b41987
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056814
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Bora Pharmaceuticals Injectables Inc
16| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Baltimore District Office | Drug Quality Assurance |
| July 25, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bora Pharmaceuticals Injectables Inc
- FDA Inspection 1308344 - 2026-03-20
- FDA Inspection 1236852 - 2024-07-25
- FDA Inspection 1215798 - 2023-08-10
- FDA Inspection 1162959 - 2022-02-18
- FDA Inspection 1140286 - 2021-04-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.